Olmesartan-associated Enteropathy with Acute Kidney Injury
- PMID: 35342171
- DOI: 10.4166/kjg.2022.007
Olmesartan-associated Enteropathy with Acute Kidney Injury
Abstract
Olmesartan, a recently introduced angiotensin II receptor blocker for hypertension, has been reported to cause drug-induced small bowel enteropathy. The diagnosis of olmesartan-associated enteropathy (OAE) needs clinical suspicion and the exclusion of coeliac disease, as it mimics coeliac sprue. Once diagnosed, it can be completely cured with the discontinuation of olmesartan. However, due to the extremely low incidence of OAE in Korea, clinical suspicion and diagnosis may be a challenge. The authors report the first case of OAE presenting with chronic diarrhea and acute kidney injury in Korea.
Keywords: Acute kidney injury; Diarrhea; Enteropathy; Olmesartan.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical